Fractyl Health Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Fractyl Health Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- GUTS
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001572616
Board of directors
-
Ajay Royan · DirectorSince 2024
-
Allan R. Will · DirectorSince 2024
-
Amy W. Schulman · DirectorSince 2024
-
Christopher Charles Thompson · DirectorSince 2025
-
Clive Meanwell · DirectorSince 2024
-
Harith Rajagopalan · Director · Chief Executive OfficerSince 2024
-
Ian Sheffield · DirectorSince 2025
-
Kelly Ann Barnes · DirectorSince 2024
-
Marc Elia · DirectorSince 2024
-
Samuel Conaway · DirectorSince 2024
-
William Bradley · DirectorSince 2024
Chief executives
Harith Rajagopalan
· Chief Executive Officer
Since February 2024
Board connections
4 of this board's directors also sit on 3 other boards.
- via Ajay Royan, Clive Meanwell and Marc Elia
- via Amy W. Schulman
- via Amy W. Schulman
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $147,149
- 6 purchases by 5 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 12, 2026 | Ajay Royan Director | Open-market purchase | +23,000 | $0.85 | $19,550 |
| Jun 10, 2026 | William Bradley Director | Open-market purchase | +68,493 | $0.73 | $50,000 |
| Jun 10, 2026 | Ian Sheffield Director | Open-market purchase | +35,000 | $0.73 | $25,550 |
| Jun 10, 2026 | Harith Rajagopalan Director, Officer (Chief Executive Officer) | Open-market purchase | +25,000 | $0.73 | $18,250 |
| Jun 8, 2026 | Smith Weber Lara Officer (Chief Financial Officer) | Open-market purchase | +20,000 | $0.69 | $13,800 |
| Dec 4, 2025 | Harith Rajagopalan Director, Officer (Chief Executive Officer) | Open-market purchase | +10,416 | $1.92 | $19,999 |
| Mar 14, 2025 | Ajay Royan Director, 10% owner | Open-market purchase | +17,901 | $1.28 | $22,913 |
| Mar 14, 2025 | Kelly Ann Barnes Director | Open-market purchase | +31,000 | $1.30 | $40,300 |
| Mar 13, 2025 | Amy W. Schulman Director | Open-market purchase | +8,550 | $1.17 | $10,004 |
| Mar 13, 2025 | William Bradley Director | Open-market purchase | +16,129 | $1.26 | $20,323 |
| Mar 13, 2025 | Samuel Conaway Director | Open-market purchase | +8,550 | $1.17 | $10,004 |
| Jan 31, 2025 | Harith Rajagopalan Director, Officer (Chief Executive Officer) | Option exercise | +90,972 | $1.70 | $154,652 |
| Jan 31, 2025 | Caplan Jay David Officer (President, Chief Product Off.) | Option exercise | +22,346 | $1.70 | $37,988 |
| Jan 31, 2025 | Harith Rajagopalan Director, Officer (Chief Executive Officer) | Open-market sale | −90,972 | $1.82 | $165,569 |
| Jan 31, 2025 | Caplan Jay David Officer (President, Chief Product Off.) | Open-market sale | −22,346 | $1.81 | $40,446 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.